Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110
Wells Fargo analyst Evan Stampler maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $94 to $110.
Stocks · News reference
8-K filing — MESA LABORATORIES INC /CO/ (MLAB)
Filed: 2026-07-30 AccNo: 0000724004-26-000082 Size: 275 KB Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Mesa Laboratories shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.
UPDATE: Mesa Laboratories Q1 Adj. EPS $2.68 Beats $2.40 Estimate, Sales $60.138M Miss $60.867M Estimate
Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.40 by 11.67 percent. This is a 15.52 percent increase over earnings of $2.32 per share from
Mesa Laboratories Q1 Adj. EPS $2.68 Beats $0.03 Estimate, Sales $60.138M Miss $60.867M Estimate
Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $0.03 by 8833.33 percent. This is a 15.52 percent increase over earnings of $2.32 per share